CenterBook Partners’s KalVista Pharmaceuticals KALV Stock Holding History

CenterBook Partners’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-53,264	Closed	-$1.07M	–	787
2026 Q1	$1.07M	Buy	+53,264	New	+$858K	0.06%	344

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CenterBook Partners's KALV Position: Q2 2026 in Review

CenterBook Partners sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 53,264 shares — an estimated $1.07M sold.

CenterBook Partners first reported a position in KALV in Q1 2026 and held it in 1 quarter. The position peaked at $1.07M in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

CenterBook Partners reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
CenterBook Partners sold 53,264 KalVista Pharmaceuticals shares in Q2 2026, an estimated $1.07M.
CenterBook Partners first reported a position in KalVista Pharmaceuticals in Q1 2026 and held it in 1 quarter.
CenterBook Partners's KalVista Pharmaceuticals position peaked at $1.07M in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.